Preferred Dental Technologies Inc.: targets International expansion beginning with Brazil, the world’s third largest dental implant market.

PDTI Preferred Dental Technologies Inc. CSE:PDTI Technology, Medical Device, 牙科,科技,医疗设备
Published on: May 29, 2018

Preferred Dental Technologies Inc. (“Company”) (CSE: PDTI, US OTC: PDTTF) has completed several meetings with a prominent Sao Paulo implantologist. Understanding the local market is essential, and PDTI successfully presented the EAS system to a practicing professional owning and operating a 5-dentist clinic in Brazil’s largest city of Sao Paulo.

Upon conclusion, the specialist had this to say about the EAS custom dental abutment; “Having had the opportunity to review the EAS system first hand, I feel that it’s control over angulation, prevention of screw loosening, ease of use and inventory control will have very strong potential in Brazil and I look forward to working with it. The EAS solves all the major dental implant problems we deal with daily.”

Brazil represents the third largest dental implant market globally and holds huge opportunity for growth. According to Euromonitor International, Brazil has the highest number of dentists in the world – almost 15% of the global total. This is driven by strong consumer demand. Despite differences in relative income, the average Brazilian household will spend nearly the same amount on dental care as a typical American household.

In its’ efforts to bring the EAS Series of dental abutments into foreign markets, Preferred Dental Technologies Inc. (PDTI) acknowledges these meetings were a result of the hard work and time spent by advisory board member, Dr. Rodrigo Franca.

We look forward to continuing developments and progress of business developments into the Brazil market following a trip in June by Dr. Franca.

This feedback reinforces PDTI’s decision to continued development of product designs and non- precious metal alternatives which are embraced by markets such as Brazil. These BRIC nations have received increasing focus from dental implant companies and should form a parallel path in commercialization due to the huge growth opportunities they provide with the aid of our advisory team.

About PDTI

Preferred Dental technologies Inc. (PDTI) has been established to advance development and commercialization of various evolutionary and disruptive technologies in the dental implant industry.

MISSION – INNOVATIVE & PRACTICAL SOLUTIONS FOR THE DENTAL INDUSTRY

Visit: www.preferreddentalimplant.com www.prefdent.com

On behalf of Preferred Dental Technologies Inc.

Erik Siegmund

Chief Executive Officer Email: [email protected] Tel: 204.691.3722

www.prefdent.com

This news release may contain forward-looking information which is not comprised of historical facts.

Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking                   information.            Forward-looking information in this news release may include, but is not limited to, the Company’s objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company’s public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither The Canadian Securities Exchange nor its Regulations Services Provider (as that term is defined in the policies of The Canadian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.

Medical Device Technology